Skip to content
lifestyle.ebusinessplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Infex Therapeutics
Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa
May 21, 2026
Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections
May 12, 2026